Keritrina Overview
- Status
-
Acquired/Merged
- Latest Deal Type
-
Asset Purch.
- Financing Rounds
-
1
Keritrina General Information
Description
A generic cardio drug product. The drug Keritrina contains the active pharmaceutical ingredient nitroglycerin which is used for the treatment of heart disease.
Contact Information
Corporate Office
- Via Filanda, 5
- Gessate
- 20060 Milan
- Italy
Corporate Office
- Via Filanda, 5
- Gessate
- 20060 Milan
- Italy
Keritrina Valuation & Funding
Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
---|
Keritrina Former Investors
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
---|
Keritrina FAQs
-
Where is Keritrina headquartered?
Keritrina is headquartered in Milan, Italy.
-
What industry is Keritrina in?
Keritrina’s primary industry is Buildings and Property.
-
Is Keritrina a private or public company?
Keritrina is a Private company.
-
What is the current valuation of Keritrina?
The current valuation of Keritrina is 00.00.
-
What is Keritrina’s current revenue?
The current revenue for Keritrina is 00000.
-
Who are Keritrina’s investors?
Keryos has invested in Keritrina.
-
When was Keritrina acquired?
Keritrina was acquired on 14-Nov-2008.
-
Who acquired Keritrina?
Keritrina was acquired by STADA Arzneimittel.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »